Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
Marta Rusek, Joanna Smith, Kamel El-Khatib, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 864-864
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues
Sneha Kumari, Rishika Dhapola, Dibbanti HariKrishnaReddy
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 943-957
Closed Access | Times Cited: 105
JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 42
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 31
Levistilide A ameliorates neuroinflammation via inhibiting JAK2/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer’s disease mouse model
H. Ni, Yanfang Liao, Yifan Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110783-110783
Closed Access | Times Cited: 24
Genkwanin: An emerging natural compound with multifaceted pharmacological effects
Naoual El Menyiy, Sara Aboulaghras, Saad Bakrim, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115159-115159
Open Access | Times Cited: 21
JAK2/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review
Siva Prasad Panda, Adarsh Kesharwani, Samaresh Datta, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176490-176490
Closed Access | Times Cited: 11
Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies
Fahad Khan, Pratibha Pandey, Meenakshi Verma, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 200-200
Open Access | Times Cited: 6
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease
Phoebe Valdes, Andrew B. Caldwell, Qing Liu, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
A Novel RAGE Modulator Induces Soluble RAGE to Reduce BACE1 Expression in Alzheimer's Disease
Seung Hyun Baek, Suji Hong, Eunae Kim, et al.
Advanced Science (2025)
Open Access
Exploring the mechanism of Radix Bupleuri in the treatment of depression combined with SARS-CoV-2 infection through bioinformatics, network pharmacology, molecular docking, and molecular dynamic simulation
Zexing Chen, Xinhua Wang, Wanyi Huang
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature
Sandra Maria Barbalho, Beatriz Leme Boaro, Jéssica da Silva Camarinha Oliveira, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 133-133
Open Access
Natural flavonoids as potential therapeutics in the management of Alzheimer’s disease: a review
Phuong‐Trang Nguyen‐Thi, Tuong Kha Vo, Thi Hong Trang Pham, et al.
3 Biotech (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 5
Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma Proteomics
Benjamin Lacar, Shadi Ferdosi, Amir Hossein Alavi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Ruxolitinib attenuates microglial inflammatory response by inhibiting NF-κB/MAPK signaling pathway
Jingli Min, Hongmei Zheng, Heye Xia, et al.
European Journal of Pharmacology (2024) Vol. 968, pp. 176403-176403
Closed Access | Times Cited: 4
Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy
Mohamad Mahjoor, Golnaz Mahmoudvand, Simin Farokhi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system
Jillian Belgrad, Qi Tang, Samuel Hildebrand, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 11, pp. 6099-6113
Open Access | Times Cited: 3
Role of prolactin in the protective effect of amisulpride against 1,2-Diacetylbenzene’s neurotoxicity
Ngoc Minh-Hong Hoang, Hai Duc Nguyen, Wonhee Jo, et al.
Environmental Toxicology and Pharmacology (2024) Vol. 107, pp. 104418-104418
Closed Access | Times Cited: 2
JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia
A. P. Young, Eileen M. Denovan‐Wright
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 2
Effect of Selenium nanoparticles on Paraquat-induced-neuroinflammation and oligodendocyte modulation: Implication of the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway
Reda Abdelnasser Imam, Fatma E. Hassan, Isra H. Ali, et al.
Tissue and Cell (2024) Vol. 89, pp. 102454-102454
Closed Access | Times Cited: 2
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2
Qi-fu-yin attenuated cognitive disorders in 5xFAD mice of Alzheimer's disease animal model by regulating immunity
Xiuzhao Yang, Tianyuan Ye, Yun He, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 7
Novel diagnostic biomarkers of oxidative stress, immunological characterization and experimental validation in Alzheimer’s disease
Di Hu, Xiaocong Mo, Luo Jihang, et al.
Aging (2023) Vol. 15, Iss. 19, pp. 10389-10406
Open Access | Times Cited: 6
Correlation between improved leptin signaling and cognitive function post bariatric surgery
Yasaman Nozari, C. Park, Elisa Brietzke, et al.
Journal of Affective Disorders (2023) Vol. 326, pp. 225-231
Closed Access | Times Cited: 5
Potential Alzheimer’s disease drug targets identified through microglial biology research
Izabela Lepiarz‐Raba, Taufik Hidayat, Anthony J. Hannan, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 587-602
Closed Access | Times Cited: 1
Jiao-tai-wan and its effective component-coptisine alleviate cognitive impairment in db/db mice through the JAK2/STAT3 signaling pathway
Kexin Nie, Yang Gao, Hongzhan Wang, et al.
Phytomedicine (2024) Vol. 134, pp. 155954-155954
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top